Dr Vimoj J. Nair is an Assistant Professor in the Division of Radiation Oncology at the University of Ottawa; and a Clinician Investigator in the Clinical Epidemiology Program (CEP) at the Ottawa Hospital Research Institute (OHRI). He also has consulting privileges as the Children’s Hospital of Eastern Ontario.
Following his radiation oncology residency from India, he pursued a neuro-oncology fellowship from Tata Memorial Hospital, India, the largest cancer hospital in Asia. He then completed a two year fellowship in Cyberknife and Stereotactic Ablative Body Radiotherapy from the University of Ottawa.
He also has completed a Master's Degree (MSc) in Clinical Trials from University of London, UK. He also has a Diploma in Computer Applications and a Professional Diploma in Clinical Research (PDCR).
After his fellowship from Ottawa, he served as a staff radiation oncologist at Prince Edward Island Cancer Treatment Centre and was an assistant professor at Dalhousie University, Halifax for 3 years.
Dr Nair has a keen interest in innovative medical research as well as the use of advanced radiation techniques in radiation oncology. As a clinical investigator and a collaborator, he holds numerous peer-reviewed research grants focusing on innovative research in Oncology.
He is a part of the RealizeLab which partakes in research involving Virtual Reality in medicine (
https://www.tohmedphys.ca/realizeLAB/).
He enjoys teaching residents; as well as involves in outreach programs to teach trainees in the developing world.
Dr Nair also serves as the Chief Editor for the
Canadian Association Of Radiation Oncology- Cureus Journal Academic Channel. 1. Belec, J., Sutherland, J., Volpini, M, Rakhra K, Granville D, La Russa D, Flaxman T, De Oliveira EP, Glikstein R, dos Santos M, MacPherson M, Aviv R,
Nair V. A Pilot Clinical and Technical Validation of an Immersive Virtual Reality Platform for 3D Anatomical Modeling and Contouring in Support of Surgical and Radiation Oncology Treatment Planning. J Digit Imaging. Inform. med. (2024). https://doi.org/10.1007/s10278-024-01048-3
2. Al-Mansor E, Mahoney M, Chenard-Poirier M, Ramjeesingh R, Nair V, Kennedy E, Locke G,Welch S, Berry S, Couture F, et al. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023. Current Oncology. 2023; 30(9):8172-8185.
https://doi.org/10.3390/curroncol30090593Zheng K, Bassal M, Mitsakakis N, Cepalo
3. T, Hamid JS, Momoli F, Reisman J, Nair V, Radhakrishnan D. A longitudinal analysis of early lung function trajectory in survivors of childhood Hodgkin lymphoma. Cancer Rep (Hoboken). 2023 Jan;6(1):e1661. doi: 10.1002/cnr2.1661. Epub 2022 Jun 27. PMID: 35760768; PMCID: PMC9875613.
4. Volpini ME, Song J, Samant R, MacDonald D, Nair VJ. Cranial Radiation Therapy as Salvage in the Treatment of Relapsed Primary CNS Lymphoma. Curr Oncol. 2022 Oct 28;29(11):8160-8170. doi: 10.3390/curroncol29110644. PMID: 36354704; PMCID: PMC9689217.
5. Puac-Polanco P, Zakhari N, Miller J, McComiskey D, Thornhill RE, Jansen GH, Nair VJ,Nguyen TB. Diagnostic Accuracy of Centrally Restricted Diffusion Sign in Cerebral Metastatic Disease: Differentiating Radiation Necrosis from Tumor Recurrence. Can Assoc Radiol J. 2022 Jul 18:8465371221115341. doi: 10.1177/08465371221115341.Epub ahead of print. PMID: 35848632.
6. Gauthier ID, Macleod CA, Sathiadoss P, McGrath TA, Nair V, Schieda N. Risk of
nephrogenic systemic fibrosis (NSF) in oncology patients receiving gadoxetic acid andupdated risk of estimate of NSF in patients receiving gadoxetic acid with moderate and severe renal impairment. Abdom Radiol (NY). 2022 Mar;47(3):1196-1201. doi:10.1007/s00261-021-03367-3. Epub 2022 Jan 7. PMID: 34997298.
7. Zuccato JA, Algan O, Nair VJ, Gunter T, Glenn CA, Dunn IF, Fung KM, Shultz DB, Zadeh G,Laperriere N, Tsang DS. Resection and radiotherapy for intracranial ependymoma: a multiinstitutional 50-year experience. J Neurosurg. 2021 Dec 24:1-8. doi:10.3171/2021.9.JNS211299. Online ahead of print. PMID: 349525121.
8.Gotfrit J, Goodwin R, Asmis T, Hyde AJ, Alcindor T, Aubin F, Berry S, Bossé D, Brown C, Burkes R, Burnell M, Colwell B, Corbett J, Craswell J, Daaboul N, Doherty M, Fleming DAB, Galvis L, Goel R, Harb M, Jeyakumar A, Jonker D, Kennedy E, Lock M, Mahmud A, McCrea PH, Nair V, Nassabein R, Nessim C, Ramjeesingh R, Raza M, Saliba W, Samimi S, Singh S, Snow S, Tehfé M, Thirlwell M, Valdes M, Welch S, Vickers M. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019. Curr Oncol. 2021 May 26;28(3):1988-2006. doi: 10.3390/curroncol28030185.
9. Burgess L, Nair V, Gratton J, Doody J, Chang L, Malone S. Stereotactic radiosurgery optimization with hippocampal-sparing in patients treated for brain metastases. Physics and Imaging in Radiation Oncology.2021,17, 106-110.
10. Song J, Samant R, Jay M, Chaudry H, Fan XY, MacDonald D, Bence-Bruckler I, Nair V. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy. Support Care Cancer. 2020 Nov;28(11):5363-5369. doi: 10.1007/s00520-020-05376-2. Epub 2020 Mar 5. PMID: 32140974.
11. Song J, Tang T, Caudrelier JM, Bélec J, Chan J, Lacasse P, Aldosary G, Nair V. Dose-sparing effect of deep inspiration breath hold technique on coronary artery and left ventricle segments in treatment of breast cancer. Radiother Oncol. 2020 Sep 17;154:101-109. doi: 10.1016/j.radonc.2020.09.019. Epub ahead of print. PMID: 32950530.
12. Nair VJ, Caudrelier JM. Hypofractionated radiotherapy for elderly breast cancer patients: from early stages disease to local palliation for unresectable disease. Translational Cancer Research. 2019.
